雷公藤多苷联合吗替麦考酚酯治疗老年IgA肾病的疗效观察  

Observation on clinical efficacy of Tripterygium Wilfordii with Mycophenolate Mofetil in the treatment of elderly IgA nephropathy

作　　者：张慧儒[1] 

机构地区：[1]河北省石家庄市第一医院,河北石家庄050011

出　　处：《中国医药导报》2013年第1期81-82,共2页China Medical Herald

摘　　要：目的探讨雷公藤多苷联合吗替麦考酚酯(mycophendate mofetil,MMF)治疗老年IgA肾病的安全性和有效性。方法将我院收治的42例老年IgA肾病患者随机分为两组,观察组22例,予以雷公藤多苷联合MMF进行治疗;对照组20例,单用MMF进行治疗。结果治疗6个月后,观察组完全缓解率和总有效率均明显高于对照组(P<0.05);两组患者的尿蛋白排泄量、血清白蛋白、血肌酐、总胆固醇等均得到了明显改善,且观察组明显高于对照组(P<0.05);观察组和对照组不良反应发生率分别为13.6%与15.0%,两者比较差异无统计学意义(P>0.05)。结论雷公藤多苷与MMF联合应用,副作用小,可以有效降低蛋白尿。Objective To explore the safety and efficacy of Tripterygium Wilfordii with Mycophenolate Mofetil（MMF） in the treatment of elderly IgA nephropathy.Methods 42 cases of elderly patients with IgA nephropathy in our hospital were randomly divided into two groups,22 cases of observation group were given the treatment of Tripterygium Wilfordii with MMF,20 cases of control group were given MMF alone.Results After treatment for 6 months,complete remission and total effective rate in the observation group were significantly higher than those in control group（P 0.05）;the improvement degree of UPE,serum albumin,Scr,TC in the observation group was significantly higher than that in control group（P 0.05）;incidence of adverse reactions in observation group and control group were 13.6% and 15.0%,there was no significant difference（P 0.05）.Conclusion Tripterygium Wilfordii with MMF for the treatment of elderly IgA nephropathy is secure and reliable and it is worth of the clinical recommendations.

关 键 词：雷公藤多苷 吗替麦考酚酯 老年 IGA肾病 

分 类 号：R692.3[医药卫生—泌尿科学]